Islet amyloid polypeptide in the islets of Langerhans: Friend or foe?

Diabetologia

Volumn 43, Issue 6, 2000, Pages 687-695

  Gebre Medhin, S ^a   Olofsson, C ^a   Mulder, H ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Alloxan induced diabetes; Beta cell survival; Calcitonin receptors; Glucose tolerance; IAPP null mutant mice; Insulin secretion; Receptor activity modifying protein (RAMP); Transgenic overexpression

Indexed keywords

AMYLIN; INSULIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; CORRELATION FUNCTION; HORMONAL REGULATION; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

EID: 0034126660     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051364     Document Type: Review

References (90)

1. 1. Opie EL (1900) On the relation of chronic interstitial pancreatitis to the islets of Langerhans and to diabetes mellitus. J Exp Med 5: 397-428
2. 2. Ehrlish JC, Ratner IM (1961) Amyloidosis of the islets of Langerhans: a restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Pathol 38: 49-59
3. 3. Westermark P (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77: 91-94
4. 4. Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827-831
5. 5. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881-3885
6. 6. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632
7. 7. Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type II (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887-892
8. 8. Clark A, Edwards CA, Ostle LR et al. (1989) Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 257:179-185
9. 9. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240-244
10. 10. Denijn M, De Weger RA, Van Mansfeld AD, van Unnik JA, Lips CJ (1992) Islet amyloid polypeptide (IAPP) is synthesized in the islets of Langerhans. Detection of IAPP polypeptide and IAPP mRNA by combined in situ hybridization and immunohistochemistry in rat pancreas. Histochemistry 97: 33-37
11. 11. Mulder H, Lindh AC, Ekblad E, Westermark P, Sundler F (1994) Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse. Gastroenterology 107:712-719
12. 12. Mulder H, Leckström A, Uddman R, Ekblad E, Westermark P, Sundler F (1995) Islet amyloid polypeptide (amylin) is expressed in sensory neurons. J Neurosci 15:7625-7632
13. 13. Mosselman S, Höppener JW, Zandberg J et al. (1988) Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett 239: 227-232
14. 14. Nishi M, Chan SJ, Nagamatsu S, Bell GI, Steiner DF (1989) Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 86: 5738-5742
15. 15. Christmanson L, Rorsman F, Stenman G, Westermark P, Betsholtz C (1990) The human islet amyloid polypeptide (IAPP) gene. Organization, chromosomal localization and functional identification of a promoter region. FEBS Lett 267: 160-166
16. 16. Muff R, Born W, Fischer JA (1995) Calcitonin, calcitonin generelated peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133:17-20
17. 17. Cooper GJ (1994) Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 15:163-201
18. 18. Ahrén B, Sundler F (1992) Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res 269: 315-322
19. 19. Fehmann HC, Weber V, Goke R, Goke B, Eissele R, Arnold R (1990) Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas. Biochem Biophys Res Commun 167:1102-1108
20. 20. Barakat A, Skoglund G, Boissard C, Rosselin G, Marie JC (1994) Calcitonin gene-related peptide and islet amyloid polypeptide stimulate insulin secretion in RINm5F cells through a common receptor coupled to a generation of cAMP. Biosci Rep 14:1-13
21. 21. Silvestre RA, Peíro E, Dégano P, Miralles P, Marco J (1990) Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 31: 23-31
22. 22. Kogire M, Ishizuka J, Thompson JC, Greeley GH Jr (1991) Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. Pancreas 6: 459-463
23. 23. Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160: 961-967
24. 24. Ar'Rajab A, Ahrén B (1991) Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. Eur J Pharmacol 192: 443-445
25. 25. Wagoner PK, Chen C, Worley JF, Dukes ID, Oxford GS (1993) Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling. Proc Natl Acad Sci USA 90: 9145-9149
26. 26. Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Macrae AD, Bloom SR (1992) Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrinol Metab 74: 1032-1035
27. 27. Nakazato M, Asai J, Kangawa K, Matsukura S, Matsuo H (1989) Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 164: 394-399
28. 28. Wang MW, Young AA, Rink TJ, Cooper GJ (1991) 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett 291:195-198
29. 29. Silvestre RA, Salas M, Dégano P, Peíro E, Marco J (1993) Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP. Biochem Pharmacol 45: 2343-2347
30. 30. Wang ZL, Bennet WM, Ghatei MA, Byfield PG, Smith DM, Bloom SR (1993) Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42: 330-335
31. 31. Young AA, Carlo P, Rink TJ, Wang MW (1992) 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol Cell Endocrinol 84: R1-R5
32. 32. Bennet WM, Beis CS, Ghatei MA, Byfield PG, Bloom SR (1994) Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia 37: 436-438
33. 33. Wang F, Adrian TE, Westermark GT, Ding X, Gässlander T, Permert J (1999) Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. Am J Physiol 276: E19-E24
34. 34. Kulkarni RN, Smith DM, Ghatei MA, Jones PM, Bloom SR (1996) Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression. J Endocrinol 151:341-348
35. 35. Gebre-Medhin S, Mulder H, Pekny M et al. (1998) Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 250: 271-277
36. 36. Ahrén B, Oosterwijk C, Lips CJ, Höppener JW (1998) Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Diabetologia 41: 1374-1380
37. 37. Leighton B, Cooper GJ (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635
38. 38. Molina JM, Cooper GJ, Leighton B, Olefsky JM (1990) Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes 39: 260-265
39. 39. Frontoni S, Choi SB, Banduch D, Rossetti L (1991) In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 40: 568-573
40. 40. Chen WJ, Armour S, Way J et al. (1997) Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors. Mol Pharmacol 52: 1164-1175
41. 41. Christmanson L, Westermark P, Betsholtz C (1994) Islet amyloid polypeptide stimulates cyclic AMP accumulation via the porcine calcitonin receptor. Biochem Biophys Res Commun 205: 1226-1235
42. 42. Sexton PM, Houssami S, Brady CL, Myers DE, Findlay DM (1994) Amylin is an agonist of the renal porcine calcitonin receptor. Endocrinology 134: 2103-2107
43. 43. Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM (1995) Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 73: 1037-1041
44. 44. Poyner D (1995) Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci 16: 424-428
45. 45. McLatchie LM, Fraser NJ, Main MJ et al. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339
46. 46. Christopoulos G, Perry KJ, Morfis M et al. (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235-242
47. 47. Muff R, Buhlmann N, Fischer JA, Born W (1999) An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140: 2924-2927
48. 48. Kahn SE, Andrikopoulos S, Verchere CB (1999) Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48: 241-253
49. 49. Beaumont K, Pittner RA, Moore CX et al. (1995) Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved. Br J Pharmacol 115: 713-715
50. 50. Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87: 5036-5040
51. 51. Porte D Jr (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 166-180
52. 52. Gebre-Medhin S, Mulder H, Zhang Y, Sundler F, Betsholtz C (1998) Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice. Brain Res Mol Brain Res 63: 180-183
53. 53. Gressens P, Marret S, Martin JL, Laquerriere A, Lombet A, Evrard P (1998) Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies. J Neurochem 70: 2574-2584
54. 54. Renström E, Ding WG, Bokvist K, Rorsman P (1996) Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 17: 513-522
55. 55. Bretherton-Watt D, Ghatei MA, Bloom SR et al. (1989) Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 32: 881-883
56. 56. Leffert JD, Newgard CB, Okamoto H, Milburn JL, Luskey KL (1989) Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci USA 86: 3127-3130
57. 57. Nagamatsu S, Nishi M, Steiner DF (1991) Biosynthesis of islet amyloid polypeptide. Elevated expression in mouse beta TC3 cells. J Biol Chem 266: 13737-13741
58. 58. Koranyi L, Tanizawa Y, Penicaud L, Atef N, Girard J, Permutt MA (1992) Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats. Diabetes 41: 685-690
59. 59. O'Brien TD, Westermark P, Johnson KH (1991) Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 40: 1701-1706
60. 60. Inoue K, Hisatomi A, Umeda F, Nawata H (1992) Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment [published erratum appears in Diabetes 1992 Nov: 41(11):1501], Diabetes 41: 723-727
61. 61. Pieber TR, Stein DT, Ogawa A et al. (1993) Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am J Physiol 265: E446-E453
62. 62. Mulder H, Ahrén B, Stridsberg M, Sundler F (1995) Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment. Diabetologia 38: 395-402
63. 63. Jamal H, Bretherton-Watt D, Suda K, Ghatei MA, Bloom SR (1990) Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. J Endocrinol 126: 425-429
64. 64. Mulder H, Ekelund M, Ekblad E, Sundler F (1997) Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects. Peptides 18: 771-783
65. 65. Swenne I (1992) Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 35: 193-201
66. 66. Mulder H, Ahrén B, Sundler F (1995) Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents. Mol Cell Endocrinol 114: 101-109
67. 67. Mulder H, Ahrén B, Sundler F (1996) Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia 39: 649-657
68. 68. Mulder H, Ahrén B, Sundler F (1997) Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats. J Endocrinol 152: 495-501
69. 69. Sussel L, Kalamaras J, Hartigan-O'Connor DJ et al. (1998) Mice lacking the homeodomain transcription factor Nk × 2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 125: 2213-2221
70. 70. Alam T, Chen L, Ogawa A, Leffert JD, Unger RH, Luskey KL (1992) Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting. Diabetes 41: 508-514
71. 71. Mulder H, Ahrén B, Sundler F (1996) Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats. Am J Physiol 271: E1008-E1014
72. 72. Fischer B, Rausch U, Wollny P, Westphal H, Seitz J, Aumuller G (1990) Immunohistochemical localization of the glucocorticoid receptor in pancreatic beta-cells of the rat. Endocrinology 126: 2635-2641
73. 73. Goodman PA, Medina-Martinez O, Fernandez-Mejia C (1996) Identification of the human insulin negative regulatory element as a negative glucocorticoid response element. Mol Cell Endocrinol 120: 139-146
74. 74. Chen L, Komiya I, Inman L, McCorkle K, Alam T, Unger RH (1989) Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry. Proc Natl Acad Sci USA 86: 1367-1371
75. 75. Koranyi L, James DE, Kraegen EW, Permutt MA (1992) Feedback inhibition of insulin gene expression by insulin. J Clin Invest 89: 432-436
76. 76. McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42: 128-138
77. 77. Verchere CB, D'Alessio DA, Palmiter RD et al. (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 3492-3496
78. 78. Soeller WC, Janson J, Hart SE et al. (1998) Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 47: 743-750
79. 79. Höppener JW, Oosterwijk C, Nieuwenhuizen MG et al. (1999) Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42: 427-434
80. 80. Janson J, Soeller WC, Roche PC et al. (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 7283-7288
81. 81. Couce M, Kane LA, O'Brien TD et al. (1996) Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Diabetes 45: 1094-1101
82. 82. Westermark GT, Leckström A, Ma Z, Westermark P (1998) Increased release of IAPP in response to long-term high fat intake in mice. Horm Metab Res 30: 256-258
83. 83. Mulder H, Mårtensson H, Sundler F, Ahrén B (2000) Insulin resistance by high fat diet differentially affects mRNA expression of insulin versus IAPP (amylin) in C57BL/6J mice. Metabolism (in press)
84. 84. Leckström A, Lundquist I, Ma Z, Westermark P (1999) Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 18: 266-273
85. 85. Leckström A, Björklund K, Permert J, Larsson R, Westermark P (1997) Renal elimination of islet amyloid polypeptide. Biochem Biophys Res Commun 239: 265-268
86. 86. Clodi M, Thomaseth K, Pacini G et al. (1998) Distribution and kinetics of amylin in humans. Am J Physiol 274:E903-E908
87. 87. Mulder H, Gebre-Medhin S, Betsholtz C, Sundler F, Ahrén B (2000) Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. Am J Physiol Endocrinol 278: E684-E691
88. 88. Khachatryan A, Guerder S, Palluault F et al. (1997) Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice. J Immunol 158: 1409-1416
89. 89. Svensson AM, Sandler S, Jansson L (1994) Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide. Diabetes 43: 454-458
90. 90. Harris PJ, Cooper ME, Hiranyachattada S et al. (1997) Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. Am J Physiol 272: F13-F21